Asset Details
Do you wish to reserve the book?
The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression
Do you wish to request the book?
The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression
2025
Overview
Loss-of-function mutations in genome maintenance genes fuel tumorigenesis through increased genomic instability. A subset of these tumor suppressors are challenging to identify due to context dependency, including functional interactions with other genes and pathways. Here, we searched for potential causal genes that impact tumor development and/or progression in breast cancer through functional-genetic screening of candidate genes. MYH4 , encoding a class II myosin, emerged as a top hit impacting genomic stability. We show that MYH4 suppresses DNA replication stress by promoting replication licensing and replication fork progression. Moreover, we observed a strong synergistic relationship among class II myosins in suppressing replication-associated DNA damage. Genomic analysis of Pan-Cancer Analysis of Whole Genomes project breast cancer samples revealed frequent concomitant loss of TP53 with MYH4 and class II myosins on chromosome 17p. Notably, Myh4 disruption accelerated mouse mammary tumorigenesis in a Trp53 -deficient background. In conclusion, our results suggest an unanticipated function of MYH4 in p53-mediated tumor suppression that can explain their combined loss in breast cancer.
Publisher
American Society for Clinical Investigation
Subject
/ Animals
/ Breast Neoplasms - metabolism
/ Breast Neoplasms - pathology
/ Cancer
/ Female
/ Genomes
/ Genomics
/ Humans
/ Mice
/ Myosin
/ Myosin Heavy Chains - genetics
/ Myosin Heavy Chains - metabolism
/ Neoplasm Proteins - genetics
/ Neoplasm Proteins - metabolism
/ Oncology
